Atlas Trials

Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye

Clinical trial NCT01027013 · COMPLETED

Trial details

NCT number
NCT01027013
Sponsor
Kubota Vision Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye SyndromesKeratoconjunctivitis Sicca
Start date
2009-12-01
Primary completion
2010-10-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.